Patent directory · USPTO A61K / A61P
Browse patents
Browse 1,585 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 1,585 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
WO 2026109729
COMBINAISON COMPRENANT LE CAPIVASERTIB ET L'ABIRATÉRONE POUR LE TRAITEMENT DU CANCER DE LA PROSTATE MÉTASTATIQUE SENSIBLE AUX HORMONES (MHSPC) DÉFICIENT EN PTEN
granted -
WO 2026078619
ASSOCIATION DE TALAZOPARIB ET D'ENZALUTAMIDE DANS LE TRAITEMENT DU CANCER DE LA PROSTATE MÉTASTATIQUE RÉSISTANT À LA CASTRATION
granted -
WO 2026078615
ASSOCIATION DE TALAZOPARIB ET D'ENZALUTAMIDE DANS LE TRAITEMENT DU CANCER DE LA PROSTATE MÉTASTATIQUE RÉSISTANT À LA CASTRATION
granted -
US 20260097057
COMBINATION OF ZIBOTENTAN AND DAPAGLIFLOZIN FOR THE TREATMENT OF CHRONIC KIDNEY DISEASE AND LIVER FIBROSIS
granted -
WO 2026027669
BIOMARQUEURS POUR DÉTERMINER LE TRAITEMENT DE LA RECTOCOLITE HÉMORRAGIQUE AVEC DU FILGOTINIB
granted -
US 20260027049
AVACOPAN FORMULATIONS
granted -
US 12533358
Methods of treatment with elinzanetant
granted -
EP 4681704
NEUE FORMULIERUNGEN VON PITOLISANT
granted -
WO 2026013310
COMPOSITION PHARMACEUTIQUE LIQUIDE À BASE DE STIRIPENTOL
granted -
WO 2025221754
UPADACITINIB DESTINÉ À ÊTRE UTILISÉ DANS LE TRAITEMENT DE L'ARTÉRITE À CELLULES GÉANTES
granted -
US 2025295738
Long-Acting Growth Hormone Dosage Forms With Superior Efficacy to Daily Somatropin
granted -
US 12419895
Methods for treating subjects with Prader-Willi syndrome
granted -
US 12414942
Compositions, methods, and systems for treating presbyopia
granted -
US 12410184
Crystalline forms of a menin inhibitor
granted -
US 12404227
Methods of making bempedoic acid and compositions of the same
granted -
US 12403090
Oral film compositions and dosage forms having precise active dissolution profiles
granted -
US 12396963
Cannabidiol-type cannabinoid compound
granted -
US 12398087
Methods of making bempedoic acid and compositions of the same
granted -
US 12390453
Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
granted -
US 12390419
Formulations of (R)-2-amino-3-phenylpropyl carbamate
granted -
US 12383545
TREATMENT OF MIGRAINE
granted -
US 12383512
Cannabidiol-type cannabinoid compound
granted -
US 12383535
Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method therefor
granted -
US 12384743
Compositions comprising (R)-2-amino-3-phenylpropyl carbamate and uses thereof
granted
Frequently asked questions
What patents are included in this directory?
We index 1,585 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.